ONC201 is a first in class small molecule impridone and DRD2 antagonist that can work by producing stress chemicals in the cancer cell and blocking it from growing and dividing.
| SparkCures ID | 229 |
|---|---|
| Developed By | Oncoceutics, Inc. |
| Generic Name | ONC201 |
| Treatment Classifications |
|
| Treatment Targets |
|
View all active clinical trials around the US.